NMYSF Stock Namsys (NMYSF, $0.51) RSI Indicator left the oversold zone on October 29, 2025

GET DAILY SIGNALS

Get AI intraday signals

NMYSF - Namsys, Inc.

RSI signal

View

Odds of UP Trend

Price: $0.51

Daily change: -$0.39 (-43.33%)

Daily volume: 1.1K

Capitalization: $26.9M

Industry: Packaged Software

This is a signal that NMYSF's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options. A.I.dvisor looked back and found 26 similar cases where NMYSF's RSI Indicator left the oversold zone, and in of them led to a successful outcome. Odds of Success:

NMYSF in +2.39% Uptrend, growing for three consecutive days on November 14, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where NMYSF advanced for three days, in of 29 cases, the price rose further within the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 11, 2025. You may want to consider a long position or call options on NMYSF as a result. In of 71 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NMYSF just turned positive on November 11, 2025. Looking at past instances where NMYSF's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

NMYSF moved above its 50-day moving average on November 14, 2025 date and that indicates a change from a downward trend to an upward trend.

NMYSF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 50-day moving average for NMYSF moved below the 200-day moving average on November 04, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

The Aroon Indicator for NMYSF entered a downward trend on November 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NMYSF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NMYSF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.416) is normal, around the industry mean (12.909). P/E Ratio (14.354) is within average values for comparable stocks, (118.249). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.777). Dividend Yield (0.000) settles around the average of (0.029) among similar stocks. P/S Ratio (4.623) is also within normal values, averaging (55.756).